Skip to main content
Erschienen in: World Journal of Urology 4/2019

17.08.2018 | Uninvited Review

Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis

verfasst von: Jack Crozier, Nathan Papa, Marlon Perera, Brian Ngo, Damien Bolton, Shomik Sengupta, Nathan Lawrentschuk

Erschienen in: World Journal of Urology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The detection of lymph node metastases in bladder cancer has a significant impact on treatment decisions. Multiple imaging modalities are available to clinicians including magnetic resonance imaging, computed tomography and positron emission tomography. We aimed to investigate the utility of alternate imaging modalities on pre-cystectomy imaging in bladder cancer for the detection of lymph node metastases.

Methods

We performed systematic search of Web of Science (including MEDLINE), EMBASE and Cochrane libraries in accordance with the PRISMA statement. Studies comparing lymph node imaging findings with final histopathology were included in our analysis. Sensitivity and specificity data were quantified using patient-based analysis. A true positive was defined as a node-positive patient on imaging and node positive on histopathology. Meta-analysis of studies was performed using a mixed-effects, hierarchical logistic regression model.

Results

Our systematic search identified 35 articles suitable for inclusion. MRI and PET have a higher sensitivity than CT while the specificity of all modalities was similar. The summary MRI sensitivity = 0.60 (95% CI 0.44–0.74) and specificity = 0.91 (95% CI 0.82–0.96). Summary PET/CT sensitivity = 0.56 (95% CI 0.49–0.63) and specificity = 0.92 (95% CI 0.86–0.95). Summary CT sensitivity = 0.40 (95% CI 0.33–0.49) and specificity = 0.92 (95% CI 0.86–0.95).

Conclusion

MRI and PET/CT provides superior sensitivity compared to CT for detection of positive lymph nodes in bladder cancer prior to cystectomy. There is variability in the accuracy that current imaging modalities achieve across different studies. A number of other factors impact on detection accuracy and these must be considered.
Literatur
1.
Zurück zum Zitat Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, Hernandez V, Espinos EL, Dunn J, Rouanne M, Neuzillet Y, Veskimae E, van der Heijden AG, Gakis G, Ribal MJ (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462–475CrossRefPubMed Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, Hernandez V, Espinos EL, Dunn J, Rouanne M, Neuzillet Y, Veskimae E, van der Heijden AG, Gakis G, Ribal MJ (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462–475CrossRefPubMed
2.
Zurück zum Zitat Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675CrossRefPubMed Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675CrossRefPubMed
3.
Zurück zum Zitat Gschwend JDP, Fair W (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41:440–448CrossRefPubMed Gschwend JDP, Fair W (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41:440–448CrossRefPubMed
4.
Zurück zum Zitat Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, Miranda G, Birkhauser F, Stein J, Burkhard FC, Daneshmand S, Thalmann GN, Gill IS, Skinner DG (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186(4):1261–1268CrossRefPubMed Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, Miranda G, Birkhauser F, Stein J, Burkhard FC, Daneshmand S, Thalmann GN, Gill IS, Skinner DG (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186(4):1261–1268CrossRefPubMed
5.
Zurück zum Zitat Yang Z, Cheng J, Pan L, Hu S, Xu J, Zhang Y, Wang M, Zhang J, Ye D, Zhang Y (2012) Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? Ann Nucl Med 26(7):571–577CrossRefPubMed Yang Z, Cheng J, Pan L, Hu S, Xu J, Zhang Y, Wang M, Zhang J, Ye D, Zhang Y (2012) Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? Ann Nucl Med 26(7):571–577CrossRefPubMed
6.
Zurück zum Zitat Maurer T, Souvatzoglou M, Kubler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U (2012) Diagnostic efficacy of 11C-choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038CrossRefPubMed Maurer T, Souvatzoglou M, Kubler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U (2012) Diagnostic efficacy of 11C-choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038CrossRefPubMed
7.
Zurück zum Zitat Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, Fleischmann A, Vermathen P, Studer UE (2009) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 55(4):761–769CrossRefPubMed Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, Fleischmann A, Vermathen P, Studer UE (2009) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 55(4):761–769CrossRefPubMed
8.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley, West Sussex, EnglandCrossRef Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley, West Sussex, EnglandCrossRef
10.
Zurück zum Zitat Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536CrossRefPubMed Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536CrossRefPubMed
11.
Zurück zum Zitat Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA (2007) A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8(2):239–251CrossRefPubMed Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA (2007) A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8(2):239–251CrossRefPubMed
12.
Zurück zum Zitat Aljabery F, Lindblom G, Skoog S, Shabo I, Olsson H, Rosell J, Jahnson S (2015) PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC Urol 15:87CrossRefPubMedPubMedCentral Aljabery F, Lindblom G, Skoog S, Shabo I, Olsson H, Rosell J, Jahnson S (2015) PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC Urol 15:87CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Rais-Bahrami S, Pietryga JA, Nix JW (2016) Contemporary role of advanced imaging for bladder cancer staging. Urol Oncol 34(3):124–133CrossRefPubMed Rais-Bahrami S, Pietryga JA, Nix JW (2016) Contemporary role of advanced imaging for bladder cancer staging. Urol Oncol 34(3):124–133CrossRefPubMed
14.
Zurück zum Zitat Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol 34(9):1229–1237CrossRefPubMed Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol 34(9):1229–1237CrossRefPubMed
15.
Zurück zum Zitat Vargas HA, Akin O, Schoder H, Olgac S, Dalbagni G, Hricak H, Bochner BH (2012) Prospective evaluation of MRI, 11C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. Eur J Radiol 81(12):4131–4137CrossRefPubMed Vargas HA, Akin O, Schoder H, Olgac S, Dalbagni G, Hricak H, Bochner BH (2012) Prospective evaluation of MRI, 11C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. Eur J Radiol 81(12):4131–4137CrossRefPubMed
16.
Zurück zum Zitat Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON (2012) 11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline. Clin Nucl Med 37(4):e67–e72CrossRefPubMed Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON (2012) 11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline. Clin Nucl Med 37(4):e67–e72CrossRefPubMed
17.
Zurück zum Zitat Ceci F, Bianchi L, Graziani T, Castellucci P, Pultrone C, Eugenio B, Martorana G, Colletti PM, Rubello D, Fanti S, Schiavina R (2015) 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. Clin Nucl Med 40(2):e124–e128CrossRefPubMed Ceci F, Bianchi L, Graziani T, Castellucci P, Pultrone C, Eugenio B, Martorana G, Colletti PM, Rubello D, Fanti S, Schiavina R (2015) 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. Clin Nucl Med 40(2):e124–e128CrossRefPubMed
18.
Zurück zum Zitat Brunocilla E, Ceci F, Schiavina R, Castellucci P, Maffione AM, Cevenini M, Bianchi L, Borghesi M, Giunchi F, Fiorentino M, Chondrogiannis S, Colletti PM, Fanti S, Martorana G (2014) Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings. Clin Nucl Med 39(5):e308–e312CrossRefPubMed Brunocilla E, Ceci F, Schiavina R, Castellucci P, Maffione AM, Cevenini M, Bianchi L, Borghesi M, Giunchi F, Fiorentino M, Chondrogiannis S, Colletti PM, Fanti S, Martorana G (2014) Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings. Clin Nucl Med 39(5):e308–e312CrossRefPubMed
19.
Zurück zum Zitat Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859–866CrossRefPubMed Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859–866CrossRefPubMed
20.
Zurück zum Zitat Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61(5):1070–1071CrossRefPubMed Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61(5):1070–1071CrossRefPubMed
21.
Zurück zum Zitat Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 198(3):552–559CrossRefPubMedPubMedCentral Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 198(3):552–559CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Amendola MA, Glazer GM, Grossman HB, Aisen AM, Francis IR (1986) Staging of bladder carcinoma: MRI–CT-surgical correlation. Am J Roentgenol 146(6):1179–1183CrossRef Amendola MA, Glazer GM, Grossman HB, Aisen AM, Francis IR (1986) Staging of bladder carcinoma: MRI–CT-surgical correlation. Am J Roentgenol 146(6):1179–1183CrossRef
23.
Zurück zum Zitat Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A (2012) Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. Urology 79(6):1317–1321CrossRefPubMed Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A (2012) Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. Urology 79(6):1317–1321CrossRefPubMed
24.
Zurück zum Zitat Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y (2008) Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 81(4):399–402CrossRefPubMed Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y (2008) Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 81(4):399–402CrossRefPubMed
25.
Zurück zum Zitat Barentsz JO, Jager G, Mugler JP, Oosterhof G, Peters H, Vanerning L, Ruijs SHJ (1995) Staging urinary-bladder cancer-value of T1-weighted 3-dimensional magnetization prepared-rapid gradient-echo and 2-dimensional spin-echo sequences. Am J Roentgenol 164(1):109–115CrossRef Barentsz JO, Jager G, Mugler JP, Oosterhof G, Peters H, Vanerning L, Ruijs SHJ (1995) Staging urinary-bladder cancer-value of T1-weighted 3-dimensional magnetization prepared-rapid gradient-echo and 2-dimensional spin-echo sequences. Am J Roentgenol 164(1):109–115CrossRef
26.
Zurück zum Zitat Chakraborty D, Mittal BR, Kashyap R, Mete UK, Narang V, Das A, Bhattacharya A, Khandelwal N, Mandal AK (2014) Role of fluorodeoxyglucose positron emission tomography/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography. World J Nucl Med 13(1):34–39CrossRefPubMedPubMedCentral Chakraborty D, Mittal BR, Kashyap R, Mete UK, Narang V, Das A, Bhattacharya A, Khandelwal N, Mandal AK (2014) Role of fluorodeoxyglucose positron emission tomography/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography. World J Nucl Med 13(1):34–39CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Chen J, Cui Y, Liu L, Li C, Tang Y, Zhou X, Qi L, Zu X (2016) CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma. Oncol Lett 11(1):735–740CrossRefPubMed Chen J, Cui Y, Liu L, Li C, Tang Y, Zhou X, Qi L, Zu X (2016) CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma. Oncol Lett 11(1):735–740CrossRefPubMed
28.
Zurück zum Zitat Daneshmand S, Ahmadi H, Huynh LN, Dobos N (2012) Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 80(6):1313–1318CrossRefPubMed Daneshmand S, Ahmadi H, Huynh LN, Dobos N (2012) Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 80(6):1313–1318CrossRefPubMed
29.
Zurück zum Zitat Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W (2005) Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95(6):786–790CrossRefPubMed Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W (2005) Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95(6):786–790CrossRefPubMed
30.
Zurück zum Zitat Gofrit ON, Mishani E, Orevi M, Klein M, Freedman N, Pode D, Shapiro A, Katz R, Libson E, Chisin R (2006) Contribution of C-11-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. J Urol 176(3):940–944CrossRefPubMed Gofrit ON, Mishani E, Orevi M, Klein M, Freedman N, Pode D, Shapiro A, Katz R, Libson E, Chisin R (2006) Contribution of C-11-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. J Urol 176(3):940–944CrossRefPubMed
31.
Zurück zum Zitat Goodfellow H, Viney Z, Hughes P, Rankin S, Rottenberg G, Hughes S, Evison F, Dasgupta P, O’Brien T, Khan MS (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int 114(3):389–395PubMed Goodfellow H, Viney Z, Hughes P, Rankin S, Rottenberg G, Hughes S, Evison F, Dasgupta P, O’Brien T, Khan MS (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int 114(3):389–395PubMed
32.
Zurück zum Zitat Heicappell R, Muller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Muller-Gartner HW, Ackermann R (1999) Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-F-18-2-deoxy-d-glucose. Eur Urol 36(6):582–587CrossRefPubMed Heicappell R, Muller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Muller-Gartner HW, Ackermann R (1999) Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-F-18-2-deoxy-d-glucose. Eur Urol 36(6):582–587CrossRefPubMed
33.
Zurück zum Zitat Hitier-Berthault M, Ansquer C, Branchereau J, Renaudin K, Bodere F, Bouchot O, Rigaud J (2013) F-18-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. Int J Urol 20(8):788–796CrossRefPubMed Hitier-Berthault M, Ansquer C, Branchereau J, Renaudin K, Bodere F, Bouchot O, Rigaud J (2013) F-18-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. Int J Urol 20(8):788–796CrossRefPubMed
34.
Zurück zum Zitat Horn T, Zahel T, Adt N, Schmid SC, Heck MM, Thalgott MK, Hatzichristodoulou G, Haller B, Autenrieth M, Kubler HR, Gschwend JE, Holzapfel K, Maurer T (2016) Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urol Int 96(1):51–56CrossRefPubMed Horn T, Zahel T, Adt N, Schmid SC, Heck MM, Thalgott MK, Hatzichristodoulou G, Haller B, Autenrieth M, Kubler HR, Gschwend JE, Holzapfel K, Maurer T (2016) Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urol Int 96(1):51–56CrossRefPubMed
35.
Zurück zum Zitat Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K (2011) Preoperative lymph-node staging of invasive urothelial bladder cancer with F-18-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol 45(2):122–128CrossRefPubMed Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K (2011) Preoperative lymph-node staging of invasive urothelial bladder cancer with F-18-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol 45(2):122–128CrossRefPubMed
36.
Zurück zum Zitat Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS (2015) FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Ann Surg Oncol 22(9):3150–3156CrossRefPubMed Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS (2015) FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Ann Surg Oncol 22(9):3150–3156CrossRefPubMed
37.
Zurück zum Zitat Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Siegel C, Cao D, Gao F, Siegel BA (2009) Prospective study of [18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 27(26):4314–4320CrossRefPubMedPubMedCentral Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Siegel C, Cao D, Gao F, Siegel BA (2009) Prospective study of [18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 27(26):4314–4320CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Li Z, Qi F, Miao J, Zu X, He W, Wang L, Qi L (2010) Vascular endothelial growth Factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma. Arch Med Res 41(8):606–610CrossRefPubMed Li Z, Qi F, Miao J, Zu X, He W, Wang L, Qi L (2010) Vascular endothelial growth Factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma. Arch Med Res 41(8):606–610CrossRefPubMed
39.
Zurück zum Zitat Liedberg F, Bendahl PO, Davidsson T, Gudjonsson S, Holmer M, Mansson W, Wallengren NO (2013) Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol. Scand J Urol 47(2):108–112CrossRefPubMed Liedberg F, Bendahl PO, Davidsson T, Gudjonsson S, Holmer M, Mansson W, Wallengren NO (2013) Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol. Scand J Urol 47(2):108–112CrossRefPubMed
40.
Zurück zum Zitat Lista F, Andres G, Caceres F, Ramon de Fata F, Rodriguez-Barbero JM, Angulo JC (2013) Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Actas Urol Esp 37(7):419–424CrossRefPubMed Lista F, Andres G, Caceres F, Ramon de Fata F, Rodriguez-Barbero JM, Angulo JC (2013) Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Actas Urol Esp 37(7):419–424CrossRefPubMed
41.
Zurück zum Zitat Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 106(5):658–663CrossRefPubMed Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 106(5):658–663CrossRefPubMed
42.
Zurück zum Zitat Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163(6):1693–1696CrossRefPubMed Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163(6):1693–1696CrossRefPubMed
43.
Zurück zum Zitat Persad R, Kabala J, Gillatt D, Penry B, Gingell JC, Smith PJB (1993) Magnetic-resonance-imaging in the staging of bladder cancer. Br J Urol 71(5):566–573CrossRefPubMed Persad R, Kabala J, Gillatt D, Penry B, Gingell JC, Smith PJB (1993) Magnetic-resonance-imaging in the staging of bladder cancer. Br J Urol 71(5):566–573CrossRefPubMed
44.
Zurück zum Zitat Picchio M, Treiber U, Beer AJ, Metz S, Bössner P, Randenborgh H, Paul R, Weirich G, Souvatzoglou M, Hartung R, Schwaiger M, Piert M (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 47(6):938–944PubMed Picchio M, Treiber U, Beer AJ, Metz S, Bössner P, Randenborgh H, Paul R, Weirich G, Souvatzoglou M, Hartung R, Schwaiger M, Piert M (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 47(6):938–944PubMed
45.
Zurück zum Zitat Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Herve JM, Botto H, Le Stanc E, Lebret T (2014) Potential impact of F-18-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. Eur J Surg Oncol 40(12):1724–1730CrossRefPubMed Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Herve JM, Botto H, Le Stanc E, Lebret T (2014) Potential impact of F-18-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. Eur J Surg Oncol 40(12):1724–1730CrossRefPubMed
46.
Zurück zum Zitat Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P (2010) FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 57(4):641–647CrossRefPubMed Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P (2010) FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 57(4):641–647CrossRefPubMed
47.
Zurück zum Zitat Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, Stief C, Tilki D (2012) Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? World J Urol 30(6):827–831CrossRefPubMed Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, Stief C, Tilki D (2012) Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? World J Urol 30(6):827–831CrossRefPubMed
48.
Zurück zum Zitat Uttam M, Pravin N, Anish B, Nandita K, Arup M (2016) Is F-18 -fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer? Int Braz J Urol 42(2):234–241CrossRefPubMedPubMedCentral Uttam M, Pravin N, Anish B, Nandita K, Arup M (2016) Is F-18 -fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer? Int Braz J Urol 42(2):234–241CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Wollin DA, Deng FM, Huang WC, Babb JS, Rosenkrantz AB (2014) Conventional and diffusion-weighted MRI features in diagnosis of metastatic lymphadenopathy in bladder cancer. Can J Urol 21(5):7454–7459PubMed Wollin DA, Deng FM, Huang WC, Babb JS, Rosenkrantz AB (2014) Conventional and diffusion-weighted MRI features in diagnosis of metastatic lymphadenopathy in bladder cancer. Can J Urol 21(5):7454–7459PubMed
Metadaten
Titel
Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis
verfasst von
Jack Crozier
Nathan Papa
Marlon Perera
Brian Ngo
Damien Bolton
Shomik Sengupta
Nathan Lawrentschuk
Publikationsdatum
17.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 4/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2439-8

Weitere Artikel der Ausgabe 4/2019

World Journal of Urology 4/2019 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.